Long-term use of broad-spectrum antibiotics affects Ly6Chi monocyte recruitment and IL-17A and IL-22 production through the gut microbiota in tumor-bearing mice treated with chemotherapy-Reference-Cited by-同舟云学术

Long-term use of broad-spectrum antibiotics affects Ly6Chi monocyte recruitment and IL-17A and IL-22 production through the gut microbiota in tumor-bearing mice treated with chemotherapy

Published:2022-09-23 Issue:6 Volume:70 Page:829-843
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Wu Yanhong^ORCID,Tang Xiaolei,Hu Feng,Zhu Tao,Liu Hui,Xiong Yanjing,Zuo Xiaoxuan,Xu Aiping,Zhuang Xiufen

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

https://link.springer.com/content/pdf/10.1007/s12026-022-09313-9.pdf

Reference70 articles.

1. Culakova E, Thota R, Poniewierski MS, Kuderer NM, Wogu AF, Dale DC, Crawford J, Lyman GH. Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study. Cancer Med. 2014;3(2):434–44. https://doi.org/10.1002/cam4.200.

2. Kuderer NM, Dale DC, Crawford J, Lyman GH. Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J clin oncol. 2007;25(21):3158–67. https://doi.org/10.1200/JCO.2006.08.8823.

3. Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer. 2011;47(1):8–32. https://doi.org/10.1016/j.ejca.2010.10.013.

4. Weycker D, Chandler D, Barron R, Xu H, Wu H, Edelsberg J, Lyman GH. Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin’s lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice. J Oncol Pharm Pract. 2017;23(1):33–42. https://doi.org/10.1177/1078155215614997.

5. Sulis ML, Blonquist TM, Stevenson KE, Hunt SK, Kay-Green S, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, et al. Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2018;65(5):e26952. https://doi.org/10.1002/pbc.26952.